LTS - Lohmann Therapy Systems
Raymond Maioran is a seasoned professional with extensive experience in the pharmaceutical and biotech industries. Currently serving as a Senior Technician at Bayer through Belcan since June 2018, Raymond provides technical support within GMP Operations. Since January 2016, Raymond has also held the role of Associate Scientist and Project Coordinator for Technology Transfer at Lohmann Therapy Systems Corp, where responsibilities include assisting with the development of transdermal and oral thin film delivery systems and creating prototypes for clients. Raymond has been involved with Lohmann Therapy Systems since January 2009 as an Associate Scientist, focusing on formulating oral dosage films for various clients. Prior experience includes positions as an Associate Scientist at Johnson & Johnson and Pfizer. Raymond holds an ABS in Business Administration and Management from Keystone College and further education at County College of Morris.
LTS - Lohmann Therapy Systems
LTS Corp is the US-based subsidiary of Lohmann Therapie Systeme whose headquarters are in Andernach, Germany. LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. In addition to the development of LTS Transdermal and LTS Oral Thin Film technologies, the company also develops innovative microneedle and the ‘active LTS Transdermal’ technology. LTS Microneedles that are long enough to penetrate the outer layer of skin but too short to irritate nerves and blood vessels. They can be used to inject active substances with larger molecules into the skin, an application that is largely pain-free. Microneedles create tiny holes in the outermost layer of skin, which significantly increases the rate at which the active substance is absorbed. LTS is currently researching a number of different microneedles made from different materials and with different gauges, designs and sizes for a wide range of applications.